Immunogenicity 15754

summary
Sample ID
3879
Response
Positive
Tumor Type
Melanoma
Gene Symbol
GANAB
Transcript ID
None
HLA INFO
A*02:01
TCR INFO

No TCR info found!

T cell Tumor cell A*02:01
sequence
Full length protein sequence (847 aa)
MTRFR
1
IDELE
6
PRRPR
11
YRVPD
16
VLVAD
21
PPIAR
26
LSVSG
31
RDENS
36
VELTM
41
AEGPY
46
KIILT
51
ARPFR
56
LDLLE
61
DRSLL
66
LSVNA
71
RGLLE
76
FEHQR
81
APRVS
86
QGSKD
91
PAEGD
96
GAQPE
101
ETPRD
106
GDKPE
111
ETQGK
116
AEKDE
121
PGAWE
126
ETFKT
131
HSDSK
136
PYGPM
141
SVGLD
146
FSLPG
151
MEHVY
156
GIPEH
161
ADNLR
166
LKVTE
171
GGEPY
176
RLYNL
181
DVFQY
186
ELYNP
191
MALYG
196
SVPVL
201
LAHNP
206
HRDLG
211
IFWLN
216
AAETW
221
VDISS
226
NTAGK
231
TLFGK
236
MMDYL
241
QGSGE
246
TPQTD
251
VRWMS
256
ETGII
261
DVFLL
266
LGPSI
271
SDVFR
276
QYASL
281
TGTQA
286
LPPLF
291
SLGYH
296
QSRWN
301
YRDEA
306
DVLEV
311
DQGFD
316
DHNLP
321
CDVIW
326
LDIEH
331
ADGKR
336
YFTWD
341
PSRFP
346
QPRTM
351
LERLA
356
SKRRK
361
LVAIV
366
DPHIK
371
VDSGY
376
RVHEE
381
LRNLG
386
LYVKT
391
RDGSD
396
YEGWC
401
WPGSA
406
GYPDF
411
TNPTM
416
RAWWA
421
NMFSY
426
DNYEG
431
SAPNL
436
FVWND
441
MNEPS
446
VFNGP
451
EVTML
456
KDAQH
461
YGGWE
466
HRDVH
471
NIYGL
476
YVHMA
481
TADGL
486
RQRSG
491
GMERP
496
FVLAR
501
AFFAG
506
SQRFG
511
AVWTG
516
DNTAE
521
WDHLK
526
ISIPM
531
CLSLG
536
LVGLS
541
FCGAD
546
VGGFF
551
KNPEP
556
ELLVR
561
WYQMG
566
AYQPF
571
FRAHA
576
HLDTG
581
RREPW
586
LLPSQ
591
HNDII
596
RDALG
601
QRYSL
606
LPFWY
611
TLLYQ
616
AHREG
621
IPVMR
626
PLWVQ
631
YPQDV
636
TTFNI
641
DDQYL
646
LGDAL
651
LVHPV
656
SDSGA
661
HGVQV
666
YLPGQ
671
GEVWY
676
DIQSY
681
QKHHG
686
PQTLY
691
LPVTL
696
SSIPV
701
FQRGG
706
TIVPR
711
WMRVR
716
RSSEC
721
MKDDP
726
ITLFV
731
ALSPQ
736
GTAQG
741
ELFLD
746
DGHTF
751
NYQTR
756
QEFLL
761
RRFSF
766
SGNTL
771
VSSSA
776
DPEGH
781
FETPI
786
WIERV
791
VIIGA
796
GKPAA
801
VVLQT
806
KGSPE
811
SRLSF
816
QHDPE
821
TSVLV
826
LRKPG
831
INVAS
836
DWSIH
841
LR
846
Mutation Information
DNA mutation:
None
Peptide Range:
197 ~ 205
Mut AA position:
None (5 in Wild Type peptide)
Alignment
Wild Type:
"ALYGSVPVL
||||.||||
Mutant:
ALYGFVPVL"
reference

J Clin Invest, 2015

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

Gene Name (from Reference) GANAB

clinic trial
Checkpoint Blockade

None

ACT

N

Vaccination

N

Curative Effect

None

experiment
minimal_peptide

Y

Antigen Type

tetramer

T-cell Source

TILs

APC Type

None

Assay

None